Jane Street’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,274
Closed -$1.8M 11752
2025
Q3
$1.41M Buy
+21,274
New +$1.27M ﹤0.01% 5602
2025
Q1
Sell
-21,203
Closed -$1.34M 9996
2024
Q4
$1.34M Sell
21,203
-3,528
-14% -$204K ﹤0.01% 4849
2024
Q3
$1.22M Sell
24,731
-7,680
-24% -$361K ﹤0.01% 5490
2024
Q2
$1.46M Sell
32,411
-8,405
-21% -$286K ﹤0.01% 5060
2024
Q1
$2.54M Buy
40,816
+19,971
+96% +$1.29M ﹤0.01% 3703
2023
Q4
$1.2M Buy
20,845
+10,196
+96% +$522K ﹤0.01% 5229
2023
Q3
$500K Buy
+10,649
New +$533K ﹤0.01% 6303
2023
Q2
Sell
-19,252
Closed -$408K 9119
2023
Q1
$408K Buy
+19,252
New +$429K ﹤0.01% 6678
2022
Q1
Sell
-1,245
Closed -$109K 10659
2021
Q4
$109K Buy
+1,245
New +$122K ﹤0.01% 9200

Other funds holding IRON

Jane Street's IRON Position: Q4 2025 in Review

Jane Street sold out of Disc Medicine (IRON) in Q4 2025, closing a stake of 21,274 shares — an estimated $1.8M sold.

Jane Street first reported a position in IRON in Q4 2021 and held it in 9 quarters. The position peaked at $2.54M in Q1 2024. 196 funds tracked by Wall St. Rank hold IRON as of Q4 2025.

  • Jane Street reported no remaining Disc Medicine position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 21,274 Disc Medicine shares in Q4 2025, an estimated $1.8M.
  • Jane Street first reported a position in Disc Medicine in Q4 2021 and held it in 9 quarters.
  • Jane Street's Disc Medicine position peaked at $2.54M in Q1 2024.
  • 196 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.